Måndag 29 December | 19:03:25 Europe / Stockholm

Svenska | English

Oculis Holding

Filter

År

Typ

Språk

Rensa

2025-12-09 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2650,00 ISK | -1,49% | 5,64 MISK

2025-12-03 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2460,00 ISK | +2,50% | 69,4 MISK

2025-11-28 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

2025-11-18 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2450,00 ISK | +1,24% | 13,2 MISK

2025-11-10 22:05:00 Oculis Reports Q3 2025 Financial Results and Provides Company Update 2450,00 ISK | +0,41% | 106 MISK

2025-11-10 22:05:00 Oculis birtir uppgjör fyrir þriðja ársfjórðung 2025 og kynnir áfanga í rekstri félagsins 2450,00 ISK | +0,41% | 106 MISK

2025-11-10 22:05:00 Oculis Reports Q3 2025 Financial Results and Provides Company Update 2450,00 ISK | +0,41% | 106 MISK

2025-11-05 10:00:00 Oculis to Participate in Upcoming November Investor Conferences 2450,00 ISK | +1,03% | 45,4 MISK

2025-10-30 09:30:44 Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development 2550,00 ISK | -3,04% | 1 478 MISK

2025-10-30 09:17:40 Oculis greinir frá umframeftirspurn í 110 milljóna USD fjármögnun sem er ætlað til að hraða klínískri þróun Privosegtor 2550,00 ISK | -3,04% | 1 478 MISK

2025-10-30 09:17:40 Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development 2550,00 ISK | -3,04% | 1 478 MISK

2025-10-14 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2600,00 ISK | +0,39% | 350 MISK

2025-10-14 10:00:00 Oculis to Spotlight Transformative Late-Stage Pipeline at Eyecelerator and AAO 2025 2590,00 ISK | +0,19% | 19,1 MISK

2025-10-08 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2530,00 ISK | +5,42% | 611 MISK

2025-10-06 10:07:00 Oculis hrindir af stað skráningarrannsóknum á Privosegtor við bráðri sjóntaugabólgu, sem gæti orðið fyrsta taugaverndandi meðferð sinnar tegundar 2190,00 ISK | +3,79% | 63,2 MISK

2025-10-06 10:07:00 Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy 2190,00 ISK | +3,79% | 63,2 MISK

2025-09-26 22:05:00 Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities

2025-09-22 10:00:00 Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS 2050,00 ISK | -1,44% | 43,9 MISK

2025-09-09 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2090,00 ISK | +1,46% | 18,1 MISK

2025-09-04 19:00:00 Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025 2080,00 ISK | +1,96% | 58,1 MISK

2025-09-03 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2040,00 ISK | +2,00% | 450 MISK

2025-09-01 10:00:00 Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences 1990,00 ISK | 0,00% | 4,79 MISK

2025-08-28 10:00:00 Oculis to Participate in Upcoming September Investor Conferences 2080,00 ISK | -2,35% | 63,9 MISK

2025-08-25 10:00:00 Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors 2170,00 ISK | -0,23% | 268 MISK

2025-08-21 22:05:00 Oculis Reports Q2 2025 Financial Results and Provides Company Update 2175,00 ISK | +0,23% | 11,5 MISK

2025-08-21 22:05:00 Oculis birtir uppgjör fyrir annan ársfjórðung 2025 og kynnir áfanga í rekstri félagsins 2175,00 ISK | +0,23% | 11,5 MISK

2025-08-12 10:00:00 Oculis to Participate in Upcoming H.C. Wainwright 5th Annual Ophthalmology Virtual Conference 2240,00 ISK | -0,44% | 3,43 MISK

2025-08-12 10:00:00 Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference 2240,00 ISK | -0,44% | 3,43 MISK

2025-08-01 10:00:00 Oculis hækkar lánsheimild sína og fær aðgang að allt að 100 milljónum CHF 2180,00 ISK | +0,46% | 0,46 MISK

2025-08-01 10:00:00 Oculis Upsized Loan Facility to Access up to CHF 100 million 2180,00 ISK | +0,46% | 0,46 MISK

2025-07-09 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2250,00 ISK | -0,88% | 32,0 MISK

2025-06-09 22:05:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2510,00 ISK | -1,18% | 16,3 MISK

2025-06-05 10:00:00 Oculis Publishes Results of 2025 Annual General Meeting 2450,00 ISK | +2,08% | 309 MISK

2025-06-05 10:00:00 Oculis birtir niðurstöður aðalfundar 2025 2450,00 ISK | +2,08% | 309 MISK

2025-06-05 10:00:00 Oculis Publishes Results of 2025 Annual General Meeting 2450,00 ISK | +2,08% | 309 MISK

2025-06-03 23:00:00 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities 2400,00 ISK | -0,83% | 116 MISK

2025-06-03 10:00:00 Oculis to Participate in Upcoming June Investor Conferences 2420,00 ISK | -1,22% | 61,2 MISK

Visa fler

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Oculis Holding

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden